The nation of Zimbabwe has turned down a substantial American health deal worth $367m (272 million pounds) spanning five years due to the United States' insistence on confidential biological samples.
The decision came to light following a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman has since stated that the US was demanding access to biological samples for scientific study and profit while was unwilling to guarantee the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged further talks to find a deal agreeable to all parties so the country's vital HIV programme can be sustained.
Broader Background
This development follows a comparable situation in Kenya, where a high court halted a related deal with the US following legal challenges were filed about the safety of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and accountability.
According to statements, Sixteen African countries have so far agreed to similar agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to share its biological resources and data indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"In essence, our country would supply the basic resources for medical research with no assurance that the end products would be available to our citizens if a future health crisis arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of one-on-one deals were upending systems previously established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its data, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration could be designed in a way that honours the independence and dignity of each country."
Health Experts Reaction
A leading public health body said it understood the government's concerns, but suggested that talks should continue since a large portion of the country's HIV programmes were funded by international support.
"If technical issues exist, such as those relating to data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," it added.
This impasse highlights the complex challenges between receiving crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.